CStone Pharmaceuticals (FRA:PH4)
Germany · Delayed Price · Currency is EUR 0.5800
-0.0050 (-0.85%)
Last updated: Jan 28, 2026, 3:25 PM CET
CStone Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -377.09 | -91.21 | -367.23 | -902.68 | -1,920 | -1,221 |
Depreciation & Amortization | 47.82 | 49.74 | 56.93 | 42.03 | 20.06 | 12.03 |
Other Amortization | 0.07 | 0.07 | 1.27 | 2.51 | 2.6 | 2.78 |
Loss (Gain) From Sale of Assets | -0.38 | -0.38 | -178.89 | - | 0.9 | - |
Asset Writedown & Restructuring Costs | 10.73 | 10.73 | 26.4 | 23.41 | - | - |
Loss (Gain) From Sale of Investments | -6.01 | -6.01 | -0.06 | 62.03 | 64.21 | -0.43 |
Stock-Based Compensation | -2.81 | -2.81 | 36.99 | 142.06 | 222.67 | 356.02 |
Other Operating Activities | 94.21 | -2.31 | -26.8 | -54.48 | 85.93 | 156.55 |
Change in Accounts Receivable | 72.16 | 48.51 | -95.31 | 40.47 | -117.6 | - |
Change in Inventory | -33.32 | -174.9 | -95.46 | 30.42 | -86.18 | - |
Change in Accounts Payable | -268.35 | -170.1 | -121.6 | -3.1 | 153.08 | 257.81 |
Change in Unearned Revenue | 35 | 35 | 70 | - | -6.76 | 1.08 |
Change in Other Net Operating Assets | -2.4 | -39.51 | 104.92 | 6.59 | 97.17 | -72.91 |
Operating Cash Flow | -430.36 | -343.18 | -588.84 | -610.74 | -1,484 | -508.07 |
Capital Expenditures | - | - | -0.02 | - | -91.03 | -67.04 |
Sale of Property, Plant & Equipment | 0.04 | 0.41 | 0.11 | - | - | - |
Sale (Purchase) of Intangibles | - | - | 151.57 | -101.82 | -58.11 | -4.41 |
Investment in Securities | -57.63 | -254.13 | 447.69 | 463.81 | -687.48 | 1,233 |
Other Investing Activities | 2.49 | 6.05 | 20.25 | 1.41 | 10.06 | 19.13 |
Investing Cash Flow | -55.09 | -247.68 | 619.61 | 363.39 | -826.55 | 1,181 |
Short-Term Debt Issued | - | 39.97 | - | - | - | - |
Long-Term Debt Issued | - | 278 | 350 | 113.04 | 96.22 | 58.58 |
Total Debt Issued | 294.36 | 317.97 | 350 | 113.04 | 96.22 | 58.58 |
Long-Term Debt Repaid | - | -312.02 | -289.98 | -75.3 | -18.5 | -6.96 |
Net Debt Issued (Repaid) | 74.02 | 5.95 | 60.02 | 37.75 | 77.72 | 51.62 |
Issuance of Common Stock | 218.23 | 0.07 | 341.82 | 2.53 | 16.83 | 1,361 |
Repurchase of Common Stock | - | - | - | - | - | -21.8 |
Other Financing Activities | -19.53 | -18.92 | -13.49 | -11.81 | -2.24 | -1.32 |
Financing Cash Flow | 272.72 | -12.9 | 388.36 | 28.47 | 92.3 | 1,389 |
Foreign Exchange Rate Adjustments | -8.36 | -4.98 | 18.87 | 34.84 | -63.55 | -163.98 |
Net Cash Flow | -221.09 | -608.73 | 437.99 | -184.04 | -2,282 | 1,898 |
Free Cash Flow | -430.36 | -343.18 | -588.86 | -610.74 | -1,575 | -575.11 |
Free Cash Flow Margin | -212.53% | -84.28% | -126.95% | -126.88% | -646.26% | -55.36% |
Free Cash Flow Per Share | -0.33 | -0.27 | -0.47 | -0.52 | -1.35 | -0.55 |
Cash Interest Paid | 10.33 | 11.9 | 10.18 | 11.81 | 2.24 | 1.32 |
Levered Free Cash Flow | -243.84 | -233.08 | -495.11 | -398.41 | -1,054 | -121.89 |
Unlevered Free Cash Flow | -235.26 | -223.6 | -487.73 | -393.11 | -1,052 | -121.06 |
Change in Working Capital | -196.91 | -301 | -137.45 | 74.37 | 39.7 | 185.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.